European regulators have recommended an update to the label of Novo Nordisk’s weight loss drug, Saxenda, to include information about the active ingredient’s ability to reduce cardiovascular risk.
Trish Webster died of acute gastrointestinal illness after several months of taking Ozempic and Saxenda Cara Lynn ... indicated," Ozempic manufacturer Novo Nordisk said in a statement to PEOPLE.
"Many people with obesity suffer from co-morbidities," said Novo Nordisk's chief science officer Mads Krogsgaard Thomsen, in a statement. "Saxenda has the potential to help some of these people ...
Novo Nordisk (NVO) markets liraglutide under the brand names Victoza, Saxenda and Xultophy. The drug is currently on the ...
NEW YORK: The U.S. health regulator approved a formulation of Novo Nordisk's diabetes drug ... The injectable drug, to be marketed as Saxenda, is the second obesity treatment to be approved ...
Novo Nordisk accepted back into UK pharma group after ‘sustained improvements’ get suspension lifted
amounted to a “large-scale Saxenda promotional campaign which Novo Nordisk knowingly paid for and which was disguised.” The resulting suspension was imposed for two years. ABPI said Monday ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback